Reglstered Company Number. 4620347
NPPG
A Private Company Limited by Guarantee
Company Number. 4620347
Registered Charity Number.. 1117648
ACCOUNTS FOR THE YEAR ENDED
31 DECEMBER 2022

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
CONTENTS
Pagè
Ref8r8nce and Adminislr8tive Details
Report of1h8 Board Ilnduding Directors, Report)
Independent Auditors, Rew)rt
Statement of Finaneial Activitiès
IlnduLliThJ Income and ￿endIture Accourtt)
Balanca Sheet
Accounting POI￿leS
No19S to Ihg Flnanclal Slalements

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
REFERENCE AND ADMINISTRATIVE DETAILS
DIRECTORS:
ARMee
S R Tomlin
N Gocxjing
N Chtisliansen
SECRETARY:
Profile Productions Limited
CHAIR..
N Christiansen
TREASURER:
P Sandorson
REGISTERED OFFICE..
Boundary Housg
Boston Road
Hanwell
London
W7 2QE
COMPANY NUMBER:
4620347
REGISTERED CHARITf NUMBER:
1117648
STATUTORY AUDITOR:
Donn8llyBentley Ltd
Chartered Accountants & Statutory Audthr
Hazlemere
70 Chorfey New Road
Bolton
Lancashire
BL14BY
BANKERS:
HS8C
525 Prescol Road
Old Swan
Liv8rpotsl
L13 5UU

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
REPORTOF THE BOARD (AS TRUSTEES AND DIRECTORS)
FOR THE YEAR ENDED 31 DECEMBER 2022
The truslges, who are also directors of the charity for the purposès of the Companies Act, are pleased
to present their annual report together wlh Ihe audited financial statemer¢ts of the charity for th8 y&ar
ended 31 December 2022. The trustees have adopted the provisM)n of the Statement of
Recommended Practice ISORPI 'Accounling and Reporb'ng by Charities, in preparing the annual
report and financial statements of the charty-
Th9 financlal st3t8m&nts have been pr8pared in accordance with the accounting policies set out in
nolgs lo the accounis and comply with the charity's govaming document, the Charities Act 2011 and
Accounting and Reporting by Charil*.' Slalemenl of Recommended Practica applicabl8 io Charities
preparing their accounls in accordancè wilh the Financial Reporting Standard Bpplicable in Ihe UK
and Repubtic of Iraland published in October 2019.
1. STRUCTURE. GOVERNANCE AND MANAGEMENT
Governlng Documont
The organlsalion is a charitable company limited by guaranteg, incorporated on 18 Decombgr 2002
and registered as a charty slnce 22 January 2007. It is govemed by its Memorandum and Articles of
Asstscialion.
As a registered charity the company is non-profit making and its dlrgclot5 and trustees ale volunteers.
The ¢ompany has been incorporated without sharg capital and il is limited by guaranleg. lo a
maximum of £1 by each of ils members.
Appointment of T￿￿te•S
The directorsllruslees are appointed by the NPPG as the directorsltrustees have the power under the
governing d￿uMents to Co-opt indNMluals who support the objects of the organisalion.
Truste• Induction
As part of their induction, the new direclorsltruslees are provided with information about the ¢harity,
the management structure, its history and working practices. In addition thèy are also provided with
axtracts ol the Memorandum and Arlcles of Association plus information from the Charlty
Commisslon and Companies House r9garding the duti8s and r8sponslbllrtles ol directors and Irustees.
The Directorsrrruslees who sarved durin9 the y&ar are listed bolow..
31 December 2022
Ms Abigail R Mee
Mr Stephen R Tomlln
Ms Diana Mowbmy Irasigned 061121221
r Nigel Gooding
Ms Nanna Christiansen (appointed 06112122)
31 December 2021
Ms Abigail R Mee
Mr Stephen R Tomlin
Ms Diana Mowbray
Mr Nigel Gooding
Members..
Rlsk rovlgw
Tha Board has wnducled its own review of tha rnalor rlsks to whl¢h the charlty Is 8xposgd and
systems have been established to mitigat8 those risks.
Organisatlonal Structuro
NPPG is managed by its Board of Members and an executive committee which meeis four limes a
year.

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
REPORT OF THE BOARD {AS TRUSTEES AND DIRECTORS)
FOR THE YEAR ENDED 31 DECEMBER 2022
Minutes from the previous meefjng and dlscusslon papers are ¢lrculalecl before the scheduled
meeting. The discussion Pa￿rS 2r8 tablèd either by a directorllruslee or the executive committee.
DUr1r￿ the meetings the progress of the past months is assessed and considered against the targets
and aims. The current statUS Df the planned work is considered and discuss¢d. Future aims and
ambitions are conshSgr8d in conjunction wilh the ongolng programme. Any disGussion papers
¢irculatsd bgforg the meeting woll be dlscussed and con8ldered.
2. OBJECTIVES AND ACTIVITIES
The principal activi14as contTrnuè to be thè advan¢ement of education and training in paediatric and
naonatal pharmacy, including thè Ur￿ertakIng ol research and the provision of informalhTh and advice
¢oni*rning paediatric and neonatal phamiacy for the benefil of the general public.
3. PUBLIC BENEFrr
Wè havé r8férrred to the guidance in the Charty Commission's general guidance on public bènefit
when reviewing our objectives and acltvrties and in planning our flrtura activili8s. In particu18r thè
trustees consider how planned activities will conlribLrte to the aims and obj8Ctivès th8y have seL
4. ACHIEVEMENTS AND PERFORMANCE IN THE YEAR
Invdvement in a joint venture to publish a Nallonal Formulary of Medlclnes for Chldrgn
IBNFCI. This is widely used by Health Care Professionals across the UK lo ensure that
medicines are used in children salèty and effectivety.
Involvement in a joint venture to devolop information leaflgts aimed al the parents of children
who are prescribed medicines for various conditions, leading to information leafiels and a
website.
Study days have continued and are now being carrled out 8ither face to face or remotely via
'TEAMS'.
The annual conferenc8 reverted back to being held face-lo-face for the first time since the
COVID-19 pandem￿.
Products"on of Conference podcasts (placed on thè NPPG wèbsilel to extend the audienc8 the
information can reach.
Annual resgarch awards resumed at the NPPG confe[er￿@ after a brfrak dug lo COVID.
Ensur9 Ihat ¢hildrgn'$ medicines practice has romained hlgh on tho aggnda of national
p)licy. induding involv•m8nt in NICE, MHRA. DH and RPS.
The NPPG specialist intere51 grDUPS helcl several training events on-line lo provide education
and support for vnembgrs and lo attract new members lo NPPG.
Continued lo produce the paedialric IV guidas in conjunclion with Medus8.
Working with the RPS as one of its affiliated $p$aalist partnership groups to aid credentialing
of education needs for our membership.

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
REPORT OF THE BOARD {AS TRUSTEES AND DIRECTORS)
FOR THE YEAR ENDED 31 DECEMBER 2022
ACHIEVEMENTS AND PERFORMANCE IN THE YEAR (Continued)
Information olficer rasponded lo sevwal consullalions from NPC. RPS, MHRA, EMA, Health,
and Care Profes5ioris Council and NICE in addilioll to responding to requests from the
membership via the website's message board.
NPPG has put a proportion of our caprtal into investments with a company "Investec- who
specialises in helping charitiès to invèst thair capital in a rèlatniely safè and low risk
mann8r. This company is managing th8 Portfolio wlh input from NPPG in accordan¢e with
our inveslmgnl policy docurnonl to onhancg fulurB Income from our capital.
Engag8d with industry to d8valop standardising drug infv$iDn concentrations for national use
within paediatrics.
Developèd an unli¢ensedlspecials formulary in conjunction with DOH to aid a reduction of
drug tariff cosls and to aid primarylsecondary care interface issues.
NPPG has now issuod soveral position statements which are being kept up¢Jaled in IKJht of
new information when it arrives.
NPPG continues lo use corporate packag9S to attract pharmacaulical industry swnsorship lo
further ils goals.
NPPG Golllinues to work with regional procurement specialists to ensure formulations
pur¢hase(I bwll be suitable for use within the paedialric population.
NPPG has taken out indemnity insurance lo cover the company shC￿d any of thèse
slalements be challenged.
NPPG has d8¢ld8d to contlnue wlth funding of the Educatlon and Training and Position
ststemenl posts lo further their work.
NPPG has been aiding the BNFC by acting as expert advisors on queries they have during
the updating process of the BNFC.
Regional subgroups have mel through the yeai to aNJ study days.
A risk register has been dgveloped for NPPG.
OnB new subgroup was developed and supported by NPPG - Rheumatology
S. FINANCIAL REVIEW
Thg dgfiGit for the year was
To which is added th8 retained surplus bioughl fotward
1113,7041
916,282
Leaving a surplus Garried forward of
802,578
NPPG general fund adfflini51ers the day lo day running of the charity. Income is derived mgmb8r
subscriptions, publicatw)ns and donations.

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
REPORTOF THE BOARD (AS TRUSTEES AND DIRECTORS)
FOR THE YEAR ENDED 31 DECEMBER 2022
5. FINANCIAL REVIEW {Continued}
Investment Policy
Under thg Memorandum and Articles of Assotiath)n. the charty has tho pow8r to invest in any way
thg trustees ￿Sh.
The trustees, having regard lo tha liquidity requirements of the charity and to tha ras8rv8$ polw.
have pla￿d a proportion of capStal Into investments with a company "Inveslec" who sp$¢ialises in
elping charities to invest théir capital in a relatively safe and low risk manner. The company will
manage the portfolio on behalf of NPPG in accordance with the charity's Invèstment policy lo enhance
future income from capital.
The remaining capital remains within intotest bearing current accounts.
Rgsgrvgs Pollcy
It is tho policy of the charity to maintain unrestricted funds. which are fr&è reserves of Ihe Charty, al a
level which equates lo approximately Six months unreslricled expenditure which would be in the
region of £76.CIOO al 31 D&¢gmber 2022. Thi5 provides sufficient funds lo cover managelnenl,
adminislratson and support costs and allows the charily lo react to changès in funding in a
constructive manner. Currently reseNes generated are £802,578. The Tru$tee8 are aware of th8
position. They arè invè8ligaling increasing eX￿ndstUr0 In aclivrties whlch SLSPPOrt thè objects of t
Charity as outlined in the plans for futurg periods.
6. PLANS FOR FUTURE PERIODS
The charfty plans conllnuing the aclivit*s as oullined in121 above in the forthcoming years by..
Continuing to furthèr develop jointly with othèr Inte￿sted parties and charities, PatTent
Informallon Leaflets (PILS) for a greater range of m9dlclngs usad in chlldren.
oiklng wSth othèr interested organisatiorss to consider ways of iisk managlng the us8 of
unlicsnsed oral liquid medklngs In children.
Upda*lng the Pagdlalrlc Intensive Care Untt package wllh a vigw to br8ak11 down ink> smaller
rrM)re manag8able solutlons which may bg possib19 to host on a web based platfom).
Continuing to provide ￿UCation and trainiThJ opportunlties for NPPG rnemb9rs by hosting all
8nnual eonfèrence and specialist study days.
F￿ll￿tatIng research and development in the field of paediatric pharmacy by hosting research
awards.
Reviewing the NPPG'S fInan￿S to ensure resources are maximised to invest in supporttng its
members lo mg¥t the Gharity's mission and vision_
NPPG lo monitor our investments carefully lo ensure income is genarated, liaising elosely
with our invgstmenl advisors.
NPPG lo promote ¢orporalg SPDn50fship packages to industy lo enhance our investments for
the company.

NPPG
A PRIVATE COMPANY LIMITED B Y GUARANTEE
REPORT OF THE BOARD (AS TRUSTEES AND DIRECTORS)
FOR THE YEAR ENDED 31 DECEMBER 2022
6. PLAMS FOR FUTURE PERIODS {Continu•dl
Continuing involvement in a joinl venture lo provKle speaalist input into materials used lo train
non-specialisl pharmacists and pre-registration pharmacists about issues relating to the safg
and effective use of rnedicines in children.
Oeveloping an electronic based eduGallonal package for paedlaM¢ oncology phan￿a￿Sts.
Maintaining a national IV database suitable for use in children and to develop one suitable for
use in neonates.
To work with likeminded pharmaceutical companies to create various tiers of corporate
sponsorship of NPPG in order to raise capital to maintain our work. in lieu of reducirKJ funds
from the contract with NICE for BNFC year on year.
To WOTk mre closély with Ihe Paediatric Chief Pharmaeisls group lo ensure similar subjects
arg boing covared by all aspects of tho profession.
To woth with CPPE to Ltpdate paediatric educational packages cn Ihelr website, and to
discuss their h051ing of the oncology packages being developed by the POP group.
NPPG will act as expert advi$ers io BNF Publications when asked to do so. NPPG will be
raviawing th8 nead for a community pharmacy link to the group.
The risk register will be regular￿ reviewed and updated as appropriate.
NPPG plans to &ngage with technician groups and develop an agenda lo support pharmacy
technicians.
7. EVENTS SINCE THE YEAR END
With the COVID19 pandemic restrictions boing largely lifted NPPG and ils m9mbers havg been able
to meet face to face for execulwg and committ8e meotings, respe¢tively. Some of these meetings are
now being held remotely.
Th& NPPG conf8r8nce for 2023 is being planned and will be held in November 2023
FUNDS
The funds held by the char￿ ar8 detailed in note 11 to the a¢counts.
. TAXATION
Exomption to taxation has been granted to thè eharitable company by virtue of its Charitab￿ status.
10. STATEMENT OF TRUSTEES AND DIRECTORS RESPONSIBILITIES
The tiuslees Iwho are also dire¢lors of NPPG for the purposes of ￿MPanY lawl are responsible lor
preparing the Trustee5' Annual Report and the financial statements in acwFdanre wilh applicablo law
and United Kingdom Accounting Standards IUnf(ed Kingdom Generally AGGepl8d Acwunling
Pr8¢ticel.

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
REPORT OF THE BOARD (AS TRUSTEES AND DIRECTORS)
FOR THE YEAR ENDED 31 DECEMBER 2022
10. STATEfvIENT OF TRUSTEES AND DIRECTORS RESPONSIBILITIES {Contlnu•d)
Company law requires the Iruslees lo prepare fi'nancial statements frjr 8ach financial year, which give
a true and fair view of the stste of affairs of the charitable company and of the incoming resources
and applic*ion of resources, including the income and expenditure. of the charitrdble Company for Ihe
year.
In preparing lhasa finanual statements the trustees ar8 required lo..
select SLtiiable accounting policies and then apply th8m consisl8ndy',
observe Ihg mglhods and principles in tha Charitiès SORP 2019.,
mak8 judgements and eslimales that are reasonabl8 and prudent..
stale whether applicable UK Accounting Standards have bgen followed-,
prepare the financial statements on the going ¢on¢ern basls unless il is inapproprrate lo
presum& that tha charitat￿6 company will continue In operallon.
The trustees are responsible for keeping proper accounting records that disclose wrth reasonable
accuracy at any time the financial posilion of the charitable company Bnd enable them to ensure that
the financial sl8lemenls comply with Ihe Companies Act 2006. They are also responsible for
Safeguarding the assets of Ihe charitable company and hence for taking reasonable stsps for the
prevention and dètèction of fr8ud and olhef irregularities.
11. STATEMEMT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
We. the trustees of the company who held Dffice at the date of approval of these Financial Ststements
as set out abov6 ea¢h confirm, so far as we are awara, that..
there is no relevant audit information of which the company's auditors 8re unaware., and
we have taken all thè slgps that we ought lo have tskgn 8s truslg98 in order to make
ourselvgs aware of any relevanl audit information and to estsblish that the company's
auditors are aware of that information.
12. SMALL COMPANY EXEMPTION
In p￿ParIng this report th¢ dire¢lors have kken a(Ivantago of the special provisions of Part 15 of the
Companies Act 2006 relaling lo small cofftpanie5.
13. AUDITORS
resolution will bo proposed al the Annual Gangral M88ting lo reappoint the Auditors,
DonnellyB8nlley Limited. Charterod Ac¢ountanl$ and Register8d Auditor.
SIGNED
BEHALF OF THE BOARD BY:_
Nanna Christiansen, Director
25 Sgptember 2023

INDEPENDENT AUDITORS, REPORT
TOTHE MEMBERS OF NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
FOR THE YEAR ENDED 31 DECEMBER 2022
Opinion
We have audlled the financkql statements of NPPG (the 'charltsble company'l for the ygar ended
31 December 2022 which comprise the statement of financial aclivilies. the balance sheet and notes
lo the financial slatgments, including a summary of signrficanl accounting polici8s. The financial
rgporting framework that has been applied In their preparation is applicable law and United Kingdom
Accounting Standards. including Financial Reporting Standard 102 The Finan￿al Reporting Standard
applicable in the UK and Republic of I￿lAn[l {United Kingdom Generally Accepted Accounting
Practice).
In our opinion the financial ststemènts..
give a true and fair view of th8 state of the charitable company's affairs as al 31 De￿rnber 2022,
and of its Incoming rgsoure9s and appll¢ation of resOuff￿s. induding its incom8 and axpandY(ure,
for the year then erKled".
have be8fb properfy prepared in accordance with United Kingdom Generalty Accepted Accounting
Practi¢o.' and
hav8 b8&n pr8par8d in ￿CordanCe with the requiram&nts of the Compani&s Act 20C6.
Basis lor oplnlon
e conductsd our audlt in accordance with Inlemational Standard5 on Audlllng (UK} IISAS IUKJI and
applicable law. Our rosponsibllitoes un¢Jer those standards ar8 further des¢rltsed In the Audoiorfs
responsibililigs for the audrt of thg finanaal slattrments section of our rewrt. We ar¢ indopendenl of
the charitable company in accordance with the ethical requirements that ar8 relevant to our audit of
the financial stslements in the UK, including the FRC'S Ethical Standard, and we have fulfilled our
other ethical responsibilities in accordanco with these requirements. We believe that the audit
@vldonGe we have obtained is sufficient and appropriate to provide a basis for our C*pinion.
Conclusions relating to going concem
In audlllng the flnanclal statements, we have conduded that the trwstees. use of the going concern
basis of accounting in Ihe preparation ol th9 financial siatemgnts r6 approprialg.
Based on the work we have perfoimad, WÈ havÈ not idèntifiéd any material une8rtainli&s relating lo
events or conditions that, individually or Collectively, may cast signifi¢ant doLJbt on the Charitat￿e
company's ability to continue as a going con¢erft ftsr a peritxl of al least iwetve month$ from when the
financial statements are aulhorised for issue.
Our responsibilities and the r8spJnsibilities of tha trust8eswilh respect to going conc8m ar&
dèscrib8d in the relavant s8ctions of this r&port.

INDEPENDENT AUDITORS REPORT
TO THE MEMBERS OF NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
FOR THE YEAR ENDED 31 DECEMBER 2022
Othor Inforniatlon
rhg other information comprises the Information Included in report of the board, other than tho
financial statements and our audilorfs report Ihereon. The Iruslees are responsible for lh& olhar
information contained within the report of the board. Our opinion on the financial statements does not
cover the other information and, except to the extent otherwise explic((ly slated in our report, we do
not express any form of assurance con¢lusiorb thereon.
Our responsibilrty is to read the other informalion and. in doing so. consider whether the other
information is materially inconsistènt wilh tha ffinancial statèments or our knowlèdg8 obtain&d in Ihè
course of the audit or otherwise appeats to be malèrialty misstated. If we identtfy s￿h material
ificonsistencies or apparent matèrial misstatèments, we are required lo delemiine whether this gives
rk%e lo a material misstatement in the finanGial ststements themselves. If, baseé on the work we have
performed. we condude that thèrg is a matèrial missialemant of this other information, wè are
required lo rsport that fa¢l.
We have nothing to report in this regard.
Oplnlon8 on other matters pre8crlbed by the Companlgs Act 20D6
In our opinion, based on the work undertaken in tha couise of the aL￿1t..
th8 information gNen in the Report of th8 Board {inco¥poraling lh8 diractors. report) for th8
nancial year for which th8 finanaal stat&mgnts are praparad is consistent with the financial
statements,. and
the directors. report hos been prepared in accordance with applicable legal requirements.
Matters on whl¢h we are requlred to report by exceptlon
In th8 light of our kno￿edge and understanding of the charitable company 8nd its environment
oblalned in th9 course of the audit. we havo not idont￿led matèrial misstsl6ments In the directors,
report.
We have nothing to ￿port in respect of the following matters in relation to whth th6 Companies Act
2006 requires us lo report lo you if. in our opinion=
adpquatg aw)unling reGords havg not bgen kgpl, or rgtums a¢Joquat¢ for our audit have not b99
re¢eNed from branches not visited by us., or
the financial Statements 8re not in agrèement with the ac¢ounlir)g records and ￿tUrft$- or
C8rt8in discloskjres of direclors. remltneration specrfied by law are not made. or
we have not received all the irbformalion and explanations we require for our autltt: or
the trustees were not enlilled lo prepare th8 financial stat8m8nls in accordance with the small
Companies, reyimo and tske advantag¢ of the small companies. exemptions in preparing the
directors, report and Irom the requirement lo prepare a strategic report.

INDEPENDENT AUDITORS REPORT
TO THE MEMBERS OF NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
FOR THE YEAR ENDED 31 DECEMBER 2022
Responslbllltios of trust•o$
As explain8d moro fully in the trustees, responsibilities stat8menl sel out on page 2.4. the Iru5ts8S
(who a￿ also the directors of the charitable company lor the purposes of company law) are
responsible for the preparation of the financial slalements and for being satisfied Ihal they give a true
and fair view, and for such internal conlrd as the twsteès determine is necessary to enable the
proparation of financial slatempnls Ihal are frae from malerial misslalemonl, whether due lo fraud or
eiror.
In preparing the fin8n¢ial slalemonts. the trustees are ￿spOnSiblÈ for assèssing the charitable
company'5 abilrty lo continue a5 a going concem, disclosing, as applicable, matters relate(I lo going
concern and using the going concern basis of accounting unless the trustees either intend lo liquidate
the charitable company or lo cease operations, or have no realisb'o alternative but to do so.
Auditor's rÈsptsnsibilitiÈs lar thè audit of thè finaneial statèmènts
Our objeGtives are to obtain reasonable assurance about whether the financial statements as a wh)le
are frge from mal8rial mi$slatemenl, whether due to fraud or error, and lo issue an auditorfs rewrt
that includes our opinion. Reasonable assurance is a high level of assurance. but is not a guarantee
that an audit conducted in accordance WFth ISAS IUK} will always delecl a material misstalerllent
whén il exists. Misslalements can arise from fraud or èrror and aré considered matèrial sf, Individually
or in the aggregate. they could reasonably be expected lo inffuence the economK dècisions of users
taken on the basis of these financial slalements.
Irragulariligs, including fraud, aro instancos of non-complianco with laws and F9gulalions. We design
Pro￿dureS in line with our responsibilities, outlined above, lo detect material misststements in respect
of irregulaiities, including fraud. The specifi'c procedures for this engagement and the extent lo which
these are capable of dete￿ing irregularities, including fraud is detailed beFow'.
We obtained an understanding of thg Iggal and regulatory framework applicable lo the charitable
CA)mpany and tho sgctor in which it operatgs and considgred the risk ol non
compliance with
applicable laws or regulations.
We detemiined that the folh)wing laws and regulations were most significant to the charitable
company.. the Companies Act 2006 and the Ch8ritiÈs A¢1 2011. Wè designed audit procedures to
respond lo the risk, recognizing that the rtsk of not delgcling a mal8rial mi88talernenl due lo fraud is
higher than the risk of not dglecting one rgsulling from error. as fraud may involve deliberate
concealment, for example, forgery or intentional misrepiesentstions. or through collusion.
We obtained an unii8rstanding of how the charitable Company is complying Wlth those legal and
regulatory frameworks by maklng enquirtes of tho management. We Corroborated our enquiries
through our r9view of board minu19S.
Our tests also induded agreeing the financial statements disdosurgs to undertying supporting
documentation. There are inherent limiialions in the audit procedures described above and. the
furthèr ramoved non-complianca with laws and regulations is from Ihg evants and transaclions
reflecled in the financial stalemgrnts. the Igss likely would b9￿m? awarg of IL Wa dld not id9ntfy
any kèy audit mattèrs rÈl8ting lo irr8gularib"ès, Including fraud.

INDEPENDENT AUDITORS REPORT
TO THE MEMBERS OF NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
FOR THE YEAR ENDED 31 DECEMBER 2022
We also addr8ss8d th8 risk of management override of intemal controls. including testing journals and
évaluating whether there was evidence of bias by the directors that represented a risk of matenal
misstatement due to fra￿1.
A further descriplh?n of our responsibilities for the audit of the financial stslements 15 located on the
Financial Reporbng Council's website al.. v•ww.frc.org.uklaudilorsresponsibililies. This description
forms part of our auditor's rèwrt.
Usp of our report
This r&port Is made solaty lo tho charilabla company's mambors, as a body, in accordancg with
Chapter 3 of Part 16 of thg Companies Act 2006. Our audh work has been undèrt8k8n so that we
mlghl state to the eharflable Company's members thos8 matters we are r8quired to stsle to them in an
audilorfs report and for no other purpose. To the fullest extent permitted by law, we do not accept or
assume ￿SpOnsIbl11ty to anyone other than the charitab19 oompany antJ Ihg charilabla company's
members as a body. Igr our audit woik, for this feport. or for the opinions w8 havè lorm6d.
Catherine Cole FCA (Senior Stslulory Auditor}
for and on behalf of DonnellyBenlley Limited
Chartered Accountant5 & Statutory Auditor
70 Chor1ey New Road
Bolton
BL148Y
25 Sèptsmber 2023

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
STATEMENT OF FINANCIAL ACTIVITIES
(INCLUDING INCOME AND EXPENDITURE ACCOUNT)
FOR THE YEAR ENDED 31 DECEMBER 2022
UNRESTRICTED
2022
2021
Note
INCOME AND EXPENDrruRE
INCOME:
Donations and legacies
Charilablg activities
Invoslmonl income
84,459
18,619
11,753
137,017
25.360
10.756
TOTAL INCOME
114,831
173.133
EXPENDITURE..
Charitable aclivilies..
Advancemenl of aducalion training in
paediatric and neonatsl pharmacy
153.698
189,169
TOTAL EXPENDITURE
153,698
189.169
NET IEXPENDITUREYINCOME
{38,8671
{16,0361
OTHER RECOGNISED GAINS AND LOSSES:
ILossllGain on revaluatK)n of fixed ass61 inv&stsm8nts
74.8371
51.373
NET MOVEMENT IN FUNDS FOR THE YEAR
{113.704}
35,337
Reconciliation of Funds
Fund Balanee Brought Forward al 1 JanuBry 2022
916.282
880,945
Fund Balance Carrth Fornard at 31 December 2022
802,578
916.282
Mtsvamants in funds a￿ dis¢losÈd in note 1110 the financTral stalem8nls.
All incoming resources and resources expended aro derived from continuing actwiti89.
There aro no other gain5 or losses other than those noted above and Iherefr>re no separate stalewEnt
of total recognised gains and losses has been prepared.
Thè accompanying accounting poli￿eS and notes form an integral part of these financial slalements.

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
BALANCE SHEET
AS AT 31 DECEMBER 2022
2022
2021
Nole
FIXED ASSETS
Investm8nts
626015
698,840
CURRENT ASSETS
Dgblors
Cash at bank
83,638
164,304
99,370
190,533
247,942
289,903
LIABIL￿lEs
Creditors falling due within one year
71,379
72.461
NET CURRENT ASSETS
176,563
217,442
NET ASS￿5
802,578
THE FUNDS OF THE CHARITY:
Unreslriclgd Funds
802,578
916.282
These accounts have been prepared in accordance with the special provision5 of Part 15 of t
CDmpanies 2006 relating to small companies and constK(Lrte the annual accounts requirèd by th8
Companles Act 2006 and are for circulation lo members of the company.
Tha financial statements on pxges 4 to 7 were approved by the Board of thè Direclofs and signed on
its behalf b
Nanna Christiansen, D￿ctor
25 Seplomber 2023

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
ACCOUNTING POLICIES
FOR THE YEAR ENDED 31 DECEMBER 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
General Information and basi¥ of preparation
MPPG 1$ a company limited by guaranteo and hag no shar& capital. In the evènt of the charity being
wound up, lh8 liabilily respect ol th8 guarant8a 18 limitad to £1 par m8mb8r of th& chamty. The
addrgss of Ihg rg91$19r9d offi¢fr Is Boundary Housg, Boslon Road, Hanwell, London, W7 2QE.
Thp nature of the charty's operations and principal actwilies are the advancement of education and
training in paedi8lric and neonatal pharmacy including the undertaking of research and the provision
of information and advice concerning paediatric and neonatal pharmacy to the benefit of the general
public.
Th& charity constfÉulgs a public bgnofil enlily as defined by FRS 102. Th8 financial stataments have
been prepared in accordance with Accounting and Raporting by Charitiès.. Statèment of
Recommended Pract￿0 appllcable to charitigs preparing Ihoir a¢¢ounts in accordance with the
Financlal Reporting Stsndard applicable in the UK and Republic of Ireland issued in October 2019.
the Flnancbal Reporting Standard applicabl8 in th6 Un(ted Kingdom and RgpLtblie of Ireland IFRS
1021, the Charrtios Act 2011. the Companios Act 2006 and UK Ganerally Ac¢ep*ad A￿untIng
Practice.
Exemption has been taken from preparing a cash Ilow stsl8ment under tha char￿e5 SORP 2019 as
gloss incorne 15 below £500.000.
Thè financial stat•m8nts ar8 preparnd on a going concarn basis undèr thè historical cosl Convenlton,
modified to indude certain items at f8ir valuè. Thè financial ststÈmÈnts are prèsèntè(J in sterling
which is the fiJn¢t￿nal Curre￿Y of the charity.
Thg significathl accounting policies applied in the preparalion of th9se financial statements are $¢1 out
balow. These policies havè b88n consisl8nlly applied to all yèars pres8nl6d unless otherwise slated.
CONSOLIDATION
The finan¢ial staltsm￿t8 cL)ntain information about NPPG as an individual company and do not
conlain consolidated information about is associate, RCPCH Publications Limited. NPPG is nol
a parent company and is therefore not required to account for tho inveslm8nt in its associate using
the 8quty method. Tha inv8stm8nt in its associ8t8 has b88n moasurad at (x>st lèss imp8irn￿nt.
FUND ACCOUNTING
Ggneral Funds are unrestricted funds which ropresenl Ihe accumulated funds o* the cOmp￿Y that are
not subject lo any restrictions regarding their Use, and are available in the fijrtherance of the general
objectives of the ¢ompany.
Designated Funds have been designated by the Board for partlcular purposes, and are also
unrestricted AS the Board can re-assign thosÈ monies if it so desires.

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
ACCOUNTING POLICIES
FOR THE YEAR ENDED 31 DECEMBER 2022
Restricted FurK15 can onty be used for th9ir stat9d puipose, duo lo specifi¢ conditions imposgd by the
providers of those funds or grants. The costs of ralsing and admlnislerlng such funds ar& charged
against the Speci￿ fund. The aim and use of each restricted fund is set out in the note$ to the
finanual slatemonts.
INCOAIE RECOGNITION POLICIES
Al Incoming r8sourcas ar8 includad in tha Slat8m8nt of Financial Activities ISOFAI wh8n th8 ¢hartty
1$18gally ontilleé to the incom8 after any performance condFtions have boen mel, the amount can b8
m8asured r81iably and tt Is probabl& that the Income wlll be received.
For donatKJns to be recognised the charity will have been notifted of the amounts and the seitlem8nt
date in writing. If the￿ are conditions attached to the donation and this requires a level of
parfomance before enlrtlemenl can be obtained then in¢ome 1$ deferred until those conditions are
fully mel ow the fulfilment of those Go[￿lI10nS is within the control of the charity and it is probable that
Ihgy will be fulfilled.
Grants or Inc(Mne rèlating to a ILrtLJf8 accounting ￿riod or raceivad in advanca ol the attributablè
Costs defeN8d and carrled forward as grants and incom8 in advance in cr8ditors.
For legacies, entillement is the eartier of the charity being notified of an impending distribution or the
legacy being received.
Investment income is earned through holding asséts for inv8slm8nt PLJfpos8s. It compris&s interest
Teceivablg on cash balance$ held in appropriate int¢￿st bearing a¢counts and dividends raceived
from shares hdd as part 018 managed invesknent portfolio.
No amount is includod in thg financial slalgmanls lor volunteers timg ifb lino with thg SORP.
EXPENDITURE
Expenditure is accounted for on an accruals basis. Expenditure is recognised wheTe there 15 a legal or
constructive oblwjation to make payments to third parties. il is probable that the settlement will ba
roqu1￿d and the amount of the obligation can be measured reliably. Expenditure in¢ludss
Irrewvgrable VAT and is roported as part of the expenditure lo which it relates.
Ch8rilable expenditure comprises those cosls incuired by the eharity in the delivery of its
activf(ies and services for its beneficiaries. It includes both costs that can be allcKated diredy
to such ￿tiVItieS and Ihose costs of an indirect nature ne￿sSary to support them.
AJI cosls are allocated b91w9911 Ihg exPend￿re calegorios on a basis designed to reflect the
use of Ihe resource. Costs relaliw lo a pariiculai activity am allo(>tèd direclly, other5 are
apportioned on an appropriate basi5.
Grants payablo lo third parties are within the tharitatAe objectives. Where unconditional
grants are off8rgd, Ihls Is accrued as soon as the recipSent is notrfied of the grant as this glves
rise to a reasonable expectation that the recipient will receive the grants. Whore grants are
condilional relating to porfomance then th& grant is only ac¢ru8d when any unfulfilled
C4)nditions are outside the control ol the charity.

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
ACCOUNTING POLICIES
FOR THE YEAR ENDED 31 DECEMBER 2022
VAT ACCOUNTING
All grant inwrne arnd dOnat￿ll5 are outside the Scope ofVAT.
Irrecoverable VAT on expenditure is not anaSysed separatety but attributed lo the category of
gxpgndlture on whlch It18 Incurred.
FIXED ASSET IMVESTMENTS
Investments are recognised initially at fair value which is normally the transaction prlce excluding
transaction costs. Subspquendy, they ale m8asured al fair value with changes recognised in 'nel
gains I Ilosse51 investments, in the SOFA rf the shares are publicty traded or their fair value can
otherwise be measured reliably. Other investments are measured at ¢osl less impairment.
Invèstmènts in associates 8rè measured At tost less impaimenl.
FOREIGN CURRENCIES
Assets and liabililigs in lorolgn curren¢S9s arg Iranslaleil into sterfing at the ratss of gxchango ruling at
the balan¢e sheet dale. Transactions in foreiqn currencies are translated into sterting at th8 rate of
exchange ruling al the date of Iransaclion. Exchange differences are taken into account in arriving al
the operating result.
DEBTORS AND CREDITORS RECEIVA8LEIPAYABLE wrrHIN ONE YEAR
Debtors and creditors with no slated interest rale aThJ receivablelpayable within one yaar ara re¢orded
at Iransaclion price. Any losses arising from impaimienl are re¢J)gnised in 0xp8ndi1u￿.
CASH AT BANK AND IN HAND
Cash at bank and In hand includes cash and short term highlyAiquid InV￿lMentS with a short maturity
of three months or less from the dale OT acquisition or opening of Ihe deposit or similar account.
TAXATION
The eh8rity is an èxempt charity within the meaning of schedule 3 of the Charities Acl 2011 and is
considered to pass the lesls OLrt in Paragraph 1 Schedule 6 Financè Act 2021 and thereforè it
meets the definibon of a charitable company for UK corporation tax purposes.
GOING CONCERN
The financlal stslements have been prepared on a going concem basis as the directors believe that
no material uncertainty exists. The direGtors have wnsidered the level of fLJnds held and the
expected level of income and expenditure for fvlelvè months from authorising these frnancial
stalemenls. The budgeted income and expenditure is suffioenl wilh the level of rosèwes for tho
charity lo be able lo continue as a going concarn.

NPPG
A PRIVATE COMPANY LIMITED B Y GUARANTEE
ACCOUNTING POLICIES
FOR THE YEAR ENDED 31 DECEMBER 2022
JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY
The preparation of these financial 5tatemen15 requires certain judgements, eslimales and
assumptions that affect the reported amDtJnts of assets, liabilities, income and expenses. Estimates
and judg8ments are ¢onlinually evaluat￿ and aro based on historical exp9rien¢9 and Othgr factors,
indudiro expectations of future events that are bdieved lo be reasonable under the circumstsncès.

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
1. INCOME
Income Is d1￿CtlY attributsble lo the principal activities of the company. All income irb 2022 and 2021
was attributable to unrestricted funds.
2. DONATIONS AMO LEGACIES
ToLIl Funds
2022
Total Fund5
2021
Donation from RCPCH Publications Ltd Isee note 121
Corporate donation
POP Sponsorship
80.744
3,715
96,532
35,485
84,459
137.017
3. INCOME FROM CHARITABLE ACTIVITIES
Total Fund¥
2022
Total Fund8
2021
Membèrs, subscriptions
Income from SOCMO study days
Incoffle from PANG St￿ days
18,619
18,620
4,740
2,000
18.619
25,360
4. INVESTMENT INCOME
Total Funds
2022
Total Fund$
2021
Bank inleresl
Income from managed inve5trnenl porlfolio
11,753
10,756
10.756

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
5. ANALYSIS OF CHARITA8LE EXPENDITURE
2022
2021
Grants
MediGines for Children
InformalK)n officer servic8S
Membership liaison offKer services
Post and stationary
Travelling exppnses
Technieal Iit8rature
Administrallon and clerical support
InsurarKe
Audit
Accountan
Sundry
Investment management costs
Loss from annual conference
Posrtion staternent offi￿1
E¢JLs¢alion and training offlcar
E19Ctronic committee votillg System
PANG study day
Treasurer
Profile disbursements
Bank charges
15.665
24,285
20,000
35,000
19,470
35.000
19,632
20
6,012
9,265
15.000
5.730
3.560
3,560
9,863
15,000
5.417
3.626
3.625
9,741
4,037
7,372
12.476
10,006
21,490
7,372
12,087
523
1,395
1,959
4,345
10
153.698
189.169
l expenditure in 2022 and 2021 was attribLrtable to unrestricted funds.
Al of the abovo costs relat8 lo direct servi¢8 provision.
Medicinès for Children is a partnership programme by NPPG, RCPCH and Wellchild whi¢h aims to
provide up lo dale leaflets and a website aimed at parents of children who are pre3¢ribgd medicines
for various conditions.
OLEring the year 8nded 31 DeG8mber 2022 a grant of £15,665 was paid lo Aklgr Hgy Chlldrgn's NHS
Foundation Trust for paediatsic research12021.. £24,285I,
Volunteers provlde impcAtsnt SUPF()rt for the charity. in partlcular through consullatkjns wllh NICE and
providing feedback and support for the positlgn slaternent officgr and Ihg educat￿￿ and Irainlng
Offi￿r.
6. STAFF COSTS
Therg arg no amployeos who receivgd total employeg bgnefrts18xcluding employer pension costs) of
more than £60,00012021'. nlll.
Neither thè Chaifman nor any olh8r directors rac8¢v6d any remuneration for their seNices during the
y8ar, thus there was no directors or key managem6nt p8rsonnel remuneration benefits (2021. nill.
Thèra w•re no employees during the year excluding directors and voluntary slaff12021.' nil).

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
7. FIXED ASSET INVESTMENTS
hlanaggd
Inve¥lment
Portfollo
Intgrost in
As¥o¢lat•d
Undertaking
Total
COST OR VALUATION..
Al 1 January 2022
Additions
Disposal
Ravaluation
698,838
11,753
19,7411
74.837
698,840
11,753
19,7411
74.837
At 31 Decemter 2022
626.013
626.015
IMPAIRMENT..
Al 1 January 2022 and 31 December 2022
4RRYING AMOUNT..
Al 31 Docember 2022
626 013
626,015
At 31 D8¢8mb&r 2021
698,838
698,840
Investments at fair value within the managed investment portfolio comprise..
2021
Equities
Securities
Cash w￿￿1n Invasbngnl portfolh)
Property within investment portfolK)
Alternativè assèts
369,808
139,999
12.171
17,964
86.071
413,153
159,469
11.756
22.845
91,615
626,013
698,838
The Investment manager Is responslble for managlng the Investment portfolio In the best Interests of
the Gharity which involves the p￿rchase and sal8 of shares. Any gains on the sale of sharès are
reinvested directly in the fund and are therefore Irealed as unrealised by th& charity.
Investmènts within lh8 managèd invèstment portlolio are valued on the basis ol mid-market prices
frorn the appropriate Stock Exchango or from th6 relevant fijnd manager at the Balance Sheet dale.
The decrease in valLbe of the investments amounting to £74,837 is an unrealised loss lo bè disclosed
under Charities SORP 2019 and does rellect any actual losses or gains reali$8d by the charlty
from sales of inveslmenls.
Investment management fees for the year to 31 December 2022 were £9.741 (2021: £10,006).
NPPG owns 50% of the ordinary share capital of RCPCH Publicatlons Limiled Ihgre is no
controlling interest. Therefore the investment in RCPCH Publications Limit￿ has beèn trèated as an
associate. 80th ttlmpanies arè ￿gIsterèo England and Wales.

NPPG
A PRIVATE COMPANY UMITED BY GUARANTEE
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
8. DEBTORS
2022
2021
Amount owed from related undertakings
Prepayments
80,744
96.532
2.838
83.638
99.370
9. CREDITORS: APIOUNTS FALLING DUE WITHIN ONE YEAR
2022
2021
A¢crual$ end deferred in¢ome
Accrual for giants payablg
55,714
15.665
48,176
24,285
71,379
72,461
10. AMALYSIS OF GROUP NET ASSETS BETWEEN FUNDS: UNRESTRICTED
2022
2021
Fixed assel investments
Currènt assèls
Current liabilities
626,015
247,942
71.379
698,840
289,903
72,461
802.578
916.282
The unrgstricled fund is used in futherancg of tho charity's pr1r￿1Pal aclivilies as 8xplained in the
report of the Board.
11. NEf MOVEMENTS IN FUNDS
Galns
and
Losses
At
0110112022
Incaming
Resources
Outgoing
Resources
At
3111212022
Unreslhcted Funds."
General Fund
916.282
114,831
153.698
74,837
802.578
The General Funds represent the free funds of the Gherity which are Tr)t designate¢J for particular
purpos8s.

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
12. NET INCOME FROM AND TRANSACTIONS WITH RELATED UNDERTAKINGS
The Charity owns 50Yo of the ordinary share capitsl of its associate RCPCH Publicats'ons LiTTriled.
ftArther details of which are given in note 7. RCPCH Publ￿atIonS Limited makes gift payments to ils
shareholders, usualty its Eolal net profit. The share due to NPPG amounts lo £80,74412021.. £96,532>
in these financlal sla19mgnls.
RCPCH Publications Limilad publishas a formulary for NPPG almad al phannaclsls. paedialricians.
gèneral practition8rs, nurse prescribers and other health ¢aw professlonals. Tho of this forTnulary
Is lo assist those who prescribe. dispense or attminisler medicines for chlldren. The fomulary is
unusual in that they Gover the off-labol use of medicinès and al80 list unlicensèd medicines neGessary
for the treatment of children.
NPPG ks ngt a parent ￿MpanY and Iherofor¢ the investmonl in RCPCH PubliGations Limitgd has not
been accounted for usiny the equtty method. Had il been accounted for u511w the equity nwthod
there would not be 8ny change lo the results of NPPG because RCPCH Publications Limited has no
accumulal8d reserves and has not made a profit or loss for the year. This Is because all tho profits of
RCPCH Publications Limit8d hav8 b88n giftad to NPPG as 3 5OVo shar8hold8r and lo the charity
Royal Coltegg ol Paedlalri¢s and Child Heabth as Ihe olhgr 500/0 shareholder.
RCPCH Publications Limited has an accounting reference dale 0131 August and a summary of ils
trading results is shown below.
RCPCH PublS¢atlons Llmlted: Summary Results
3110812022
3110812021
Turnover
Cost of sales and administratNe expenses
200.463
39,032
231,402
38.353
0￿rating profil
161,431
193.049
Interest recelvable
57
15
N8t Profit
161.488
193,064
Charitable Trading Funds..
8alance al 1 September
Net profit
To be gifted lo RCPCH for year ended 31 August
To ba glfted lo NPPG for yaar gndgd 31 August
161.488
(80,7441
80,744
193,064
(96,5321
96,532
Balarbca at 31 August
Charity shar8-
Balance al 1 September
Balance al 31 August

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
Tha British NalK)nal Formulary for Children IBNFCI is produced a5 a joint venture. the arrangements
for which were fornialised in an agreement between RCPCH Publications Lirllited, The Royal
Phamiaceulical Society and BMJ PL)blishing Group Limited dated 13 April 2005. Thg joint ventures
thèn entered into a three year supply agreement with the Department of Health dated 20 September
2005 to 9nsure all rglevanl health professionals in England r8c6ived tho BNFC. On 9 Mar¢h 2011.
the PaediatrSG Publi¢ations Board considered. agreed and sign8d tha naw BNFC contract wrth NICE
{Nalional Institute of Clinical Exc8llenGo1 for the bulk purchas8 of the formulary over the next eight
y9ars.
The flrst edition ol the BNFC was published in September 2005 with tho website going live Ihat month
and publication of a c￿Rom vèrsion in October 2005. The year ended 31 August 2022 principally
includes the companls Sha￿ of income associated with developing and publishing the elghleenth
edition of BNFC.
During 20218 new tsvelve year contract was signed with NICE.
13. RELATED PARTY TRANACTIONS
There were no related party Iransaclions.
14. TRANSACTIONS WITH DIRECTORS AND TRUSTEES
None of lh8 direciors receivod any remuneration for thgir services during the year.
The direGtors were reimbursed £1.191 12021.. nil) for costs incurred during the year.
15. ULTIMATE CONTROLUNG PARTY
The charitable company under the control of the Board.
16. FINANCIAL COP4lMITMENTS
Total financial commitments which are not included in the balance sheet are nil12021.' £15.6651.

NPPG
A PRIVATE COMPANY LIMITED BY GUARANTEE
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
17. FINANCIAL INSTRUMENTS
The carrying amounts of the charity's flnoncial ststemonts arè as follows..
3111212022
3111212021
Mgasur8d at lair valu8 through nel incomelexpenditure..
Fixed asset listed investments fr￿18 71
626013
698,838
Debit instruments measured at amortksed cost..
Other debtors Inole 81
mount owed by related undertakings Inote 8}
2,894
80,744
2,838
99.370
Finan¢ial liabilities mgasured al amortised cost..
Accruals and deferred incomg Inole 91
Accrual frjr grants payable (note 91
55,714
15,665
48,176